Sen. John McCain (R-Ariz.), whose 82nd birthday is this week, was diagnosed with an aggressive form of brain cancer last year. "In the year since, John has surpassed expectations for his survival. But the progress of disease and the inexorable advance of age render their verdict. With his usual strength of will, he has now chosen to discontinue medical treatment," McCain's family said in a statement.
from Kaiser Health News https://ift.tt/2BEOqqd
August 24, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Listen: NPR Interview About Less Lethal Weapons That Can Maim Or KillThe streets in many U.S. cities have erupted with protests recently and police and federal officers have fired rubber bullets and other projectiles into crowds, injuring or even blinding some of the participants. This has bee… Read More
What Seniors Can Expect as Their New Normal in a Post-Vaccine WorldImagine this scenario, perhaps a year or two in the future: An effective COVID-19 vaccine is routinely available and the world is moving forward. Life, however, will likely never be the same — particularly for people over 60.… Read More
Hospital Merger in Washington State Stokes Fears About Catholic Limits on CareThe proposed merger of a well-regarded secular hospital system and a larger Roman Catholic system in Washington state has triggered new alarms about religious restrictions on patients’ access to care. Virginia Mason Health Sy… Read More
California GOP Consultant Rues ‘Big Mistake’ That Led to Family’s COVID InfectionsSACRAMENTO — The tweet Richard Costigan posted July 23 was bluntly honest: “We tried our best to limit exposure to #COVID19 but we slipped up somewhere.” Costigan tweeted while waiting anxiously in the parking lot of a hospit… Read More
Listen: ACA Heading to Supreme Court — AgainJulie Rovner, KHN’s chief Washington correspondent, joins “SCOTUStalk” podcast host Amy Howe to talk about the upcoming Supreme Court hearing on the Affordable Care Act. The two look at the law’s history before the court — it… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment